A new cancer detection test to analyze volatile organic compounds through urine analysis, was granted the Breakthrough Device Designation status by the U.S. FDA. The system, which is built on gas ...

A new review was published in Volume 16 of Oncotarget on June 17, 2025, titled "Optimizing enfortumab vedotin plus pembrolizumab therapy." ...

Cancer relapse refers to the reappearance of malignant cells after a period of remission. It can occur months to decades post ...

PFE's robust late-stage pipeline, recent FDA wins and deep oncology bets position it for long-term growth through 2030.

The QUILT-88 study reveals promising survival rates for advanced pancreatic cancer patients using a multimodal treatment ...

Protara Therapeutics, Inc. (Nasdaq: TARA) ('Protara” or the 'Company”), a clinical-stage company developing transformative ...

The Lustgarten Foundation, the world's largest private funder of pancreatic cancer research, today announced the appointment of Arthur Kuan, MS, to its Board of Directors. Mr. Kuan is the Chairman and ...

In an exclusive interview, the band's lyricist opens up on how they came together, made their most beloved records and got ...

Mengeling, the fourth bishop of the Diocese of Lansing, died in the early hours of July 1, the Diocese announced on its ...

With closures of rural hospitals like the one in Thomasville, some hospitals’ emergency rooms in urban areas of Alabama ...

Cancer is often linked to old age. Many people think it happens late in life. But a quiet shift is happening now, especially with cancers in your stomach and bowels. It isn’t just an old person’s ...

Regular screening can bend the odds in your favor when it comes to four types of cancers. The science is less clear for the rest.